Review
doi: 10.1097/MAJ.0b013e3181c70e14.
Delayed hemolytic transfusion reaction in sickle cell disease
Affiliations
- PMID: 20051821
- PMCID: PMC2837790
- DOI: 10.1097/MAJ.0b013e3181c70e14
Item in Clipboard
Review
Delayed hemolytic transfusion reaction in sickle cell disease
Am J Med Sci.
2010 Mar.
Abstract
Delayed hemolytic transfusion reactions are potentially life-threatening complications observed in patients with sickle cell disease. We review the clinical features, pathophysiology, laboratory evaluation, and management of this complication. It is important that delayed hemolytic transfusion reactions be included in the differential diagnosis of acute pain episodes following a red blood cell transfusion in a patient with sickle cell disease.
Similar articles
-
Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.Pediatrics. 2003 Jun;111(6 Pt 1):e661-5. doi: 10.1542/peds.111.6.e661. Pediatrics. 2003. PMID: 12777582
-
Delayed hemolytic transfusion reactions in sickle cell anemia.South Med J. 1989 Aug;82(8):1034-6. doi: 10.1097/00007611-198908000-00025. South Med J. 1989. PMID: 2762885
-
Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.Transfus Clin Biol. 2019 May;26(2):94-98. doi: 10.1016/j.tracli.2019.02.002. Epub 2019 Feb 22. Transfus Clin Biol. 2019. PMID: 30837199 Review.
-
Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.J Pediatr Hematol Oncol. 2008 Dec;30(12):928-30. doi: 10.1097/MPH.0b013e31818c9172. J Pediatr Hematol Oncol. 2008. PMID: 19131783
-
Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature.J Pediatr Hematol Oncol. 2019 Nov;41(8):624-626. doi: 10.1097/MPH.0000000000001307. J Pediatr Hematol Oncol. 2019. PMID: 30179992 Review.
Cited by
-
Interventions for chronic kidney disease in people with sickle cell disease.Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3. Cochrane Database Syst Rev. 2023. PMID: 37539955 Free PMC article. Review.
-
Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Series.Am J Case Rep. 2022 Jan 5;23:e934681. doi: 10.12659/AJCR.934681. Am J Case Rep. 2022. PMID: 34983921 Free PMC article.
-
Preoperative blood transfusions for sickle cell disease.Cochrane Database Syst Rev. 2020 Jul 2;7(7):CD003149. doi: 10.1002/14651858.CD003149.pub4. Cochrane Database Syst Rev. 2020. PMID: 32614473 Free PMC article.
-
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.Cochrane Database Syst Rev. 2020 Apr 6;4(4):CD012389. doi: 10.1002/14651858.CD012389.pub3. Cochrane Database Syst Rev. 2020. PMID: 32250453 Free PMC article.
-
Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.Cochrane Database Syst Rev. 2019 Oct 25;2019(10):CD008360. doi: 10.1002/14651858.CD008360.pub5. Cochrane Database Syst Rev. 2019. PMID: 31684693 Free PMC article.
References
-
- Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood. 1993;81:1109–1123. - PubMed
-
- King KE, Ness PM. Treating anemia. Hematol Oncol Clin North Am. 1996;10:1305–1320. - PubMed
-
- Vichinsky E. Transfusion. In: Embury SH, Embury SH, Hebbel, Mohandas, Steinberg, editors. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven Press; 1994. pp. 781–798.
-
- Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42:37–43. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
